Application 213691
- Type
- NDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | IMPEKLO | CLOBETASOL PROPIONATE | LOTION;TOPICAL | 0.05% W/W | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N213691-001 | IMPEKLO | CLOBETASOL PROPIONATE | 0.05% | LOTION / TOPICAL | RLD | 2020-05-19 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N213691-001 | IMPEKLO | 0.05% | LOTION / TOPICAL | RLD | 2020-05-19 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clobetasol Propionate | CLOBETASOL PROPIONATE | A-S Medication Solutions | b3343e4f-fc6c-4f69-9ccc-279f606683c5 | 2026-11-03 | Adverse reactions | CLOBETASOL PROPIONATE |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | A-S Medication Solutions | ecef6314-97c0-4f2e-bbcb-53a62ac7fb72 | 2026-10-27 | Adverse reactions | CLOBETASOL PROPIONATE |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Xiromed, LLC | 56e6d233-d9ee-f022-3be7-d100799a561e | 2026-10-26 | Adverse reactions | CLOBETASOL PROPIONATE |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | Zydus Pharmaceuticals USA Inc. | 98a25409-e84e-452b-8dc5-ad87842398e1 | 2026-10-21 | Adverse reactions | CLOBETASOL PROPIONATE |
| clobetasol propionate | CLOBETASOL PROPIONATE | Zydus Lifesciences Limited | 287ce325-4449-4342-a9ef-a7e31ee692bd | 2026-10-05 | CLOBETASOL PROPIONATE | |
| clobetasol propionate | CLOBETASOL PROPIONATE | Zydus Pharmaceuticals USA Inc. | 8618a3bc-5601-4273-a708-27b0ecd4c385 | 2026-10-05 | Warnings, Adverse reactions | CLOBETASOL PROPIONATE |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | Alembic Pharmaceuticals Inc. | a83d212b-a970-4ee7-8431-fead6b2e7f9d | 2026-07-17 | Warnings, Adverse reactions | CLOBETASOL PROPIONATE |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | AvKARE | a86241e0-3187-e468-e053-2995a90a1ae5 | 2026-07-15 | Adverse reactions | CLOBETASOL PROPIONATE |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Sun Pharmaceutical Industries, Inc. | d8f560c8-e223-46f0-8afb-b418f2b6399c | 2026-07-14 | Warnings, Adverse reactions | CLOBETASOL PROPIONATE |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | Alembic Pharmaceuticals Inc. | 91e7bf57-d236-4b9b-8241-e71e5e93617a | 2026-07-09 | Warnings, Adverse reactions | CLOBETASOL PROPIONATE |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | A-S Medication Solutions | 446209ba-61ad-46b5-99f7-039ae7fca757 | 2026-07-06 | Adverse reactions | CLOBETASOL PROPIONATE |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | A-S Medication Solutions | 8da21ad7-4d2d-4168-82ee-ebf13ce5e923 | 2026-06-23 | Adverse reactions | CLOBETASOL PROPIONATE |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Amneal Pharmaceuticals NY LLC | 4363539b-d25e-4da3-911c-9ba142d7f4f4 | 2026-06-19 | Warnings, Adverse reactions | CLOBETASOL PROPIONATE |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Torrent Pharmaceuticals Limited | 6f930298-e410-4bfb-8c3f-456a1f55f4a9 | 2026-05-08 | Adverse reactions | CLOBETASOL PROPIONATE |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | Golden State Medical Supply, Inc. | 04180cdf-c63a-d524-e063-6394a90a2d06 | 2026-04-23 | Adverse reactions | CLOBETASOL PROPIONATE |
| Clobetasol Propionate (emollient) | CLOBETASOL PROPIONATE | Bryant Ranch Prepack | cb0bc057-d6ab-4eea-af7a-01661ae9b517 | 2026-04-23 | Warnings, Adverse reactions | CLOBETASOL PROPIONATE |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | Encube Ethicals, Inc. | 8ad5f9b0-b50a-4d1f-a0c1-704b5b72bf65 | 2026-04-21 | Adverse reactions | CLOBETASOL PROPIONATE |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | A-S Medication Solutions | c26e6e8f-9670-48c5-917b-e73e5589579a | 2026-04-14 | Adverse reactions | CLOBETASOL PROPIONATE |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Sun Pharmaceutical Industries, Inc. | 4a761afb-a48a-4a5a-8700-ad93601a260f | 2026-03-23 | Adverse reactions | CLOBETASOL PROPIONATE |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | Micro Labs Limited | 85aea21d-c4ff-4558-b416-516fa93bea1f | 2026-03-16 | Adverse reactions | CLOBETASOL PROPIONATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 49502-537 | IMPEKLO | clobetasol propionate | Mylan Specialty L.P. | NDA | Current |
| 49502-537 | IMPEKLO | clobetasol propionate | Mylan Specialty L.P. | NDA | Current |
| 49502-537 | IMPEKLO | clobetasol propionate | Mylan Specialty L.P. | NDA | Current |
| 49502-537 | IMPEKLO | clobetasol propionate | Mylan Specialty L.P. | NDA | Current |